# Pilot Study of Effects of Duavee® on Imaging and Blood Biomarkers In Women With Menopausal Symptoms

> **NCT04379024** · EARLY_PHASE1 · TERMINATED · sponsor: **Carol Fabian, MD** · enrollment: 11 (actual)

## Conditions studied

- Focus of Study is Healthy Women at Risk for Breast Cancer

## Interventions

- **DRUG:** DUAVEE 0.45Mg-20Mg Tablet

## Key facts

- **NCT ID:** NCT04379024
- **Lead sponsor:** Carol Fabian, MD
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-06-01
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-07-31
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Study agent no longer available
- **Last updated:** 2021-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04379024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04379024, "Pilot Study of Effects of Duavee® on Imaging and Blood Biomarkers In Women With Menopausal Symptoms". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04379024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*